Osimertinib, 3rd Generation EGFR-TKI, Targeted for EGFR-mutated NSCLC, Inhibits EGFR Ex19Del and L858R mutations, CNS metastasis activity, For EGFRm NSCLC patients,
Sale!
Lucius
Replica Osimertinib EGFR-TKI for NSCLC with EGFR Ex19Del/L858R
Original price was: $648.00.$489.00Current price is: $489.00.
Osimertinib, 3rd Generation EGFR-TKI, Targeted for EGFR-mutated NSCLC, Inhibits EGFR Ex19Del and L858R mutations, CNS metastasis activity, For EGFRm NSCLC patients,